---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-187995"
form_type: "8-K"
ticker: "CERS"
cik: "0001020214"
company_name: "CERUS CORP"
filed_at: "2022-07-05T23:59:59+00:00"
generated_at: "2026-06-24T21:10:07.516726+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cerus appoints Dr. Hua Shan to Board of Directors effective July 1, 2022

## Summary
- Dr. Hua Shan, Medical Director of Transfusion Medicine at Stanford, joins Cerus Board effective July 1, 2022.
- She brings over 25 years of transfusion medicine experience, including expertise in Chinese blood bank practices.
- Receives $45k annual cash retainer and initial equity grants valued at $150k in options and $150k in RSUs, vesting over 3 years.
- Appointment supports Cerus's JV to bring INTERCEPT Blood System to China and global expansion.

## SEC filing metadata
- accession: 0001193125-22-187995
- form_type: 8-K
- ticker: CERS
- cik: 0001020214
- company_name: CERUS CORP
- filed_at: 2022-07-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1020214/000119312522187995/0001193125-22-187995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1020214/000119312522187995/d357061d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-187995
- JSON: https://secwatch.observer/filing/0001193125-22-187995.json
- Plain text: https://secwatch.observer/filing/0001193125-22-187995.txt

## Key facts
- Executive change
  Hua Shan was appointed as Director at CERUS CORP.
  - Action: appointed
  - Role: Director
  source text: the Board extended an offer to join the Board to Hua Shan, MD, PhD, and on June 30, 2022, Dr. Shan accepted such offer to join the Board, effective July 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1020214/000119312522187995/0001193125-22-187995-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.